Fingerprint
Dive into the research topics of 'An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma
Mark Agulnik, Brian Schulte, Steven Robinson, Angela C. Hirbe, Kevin Kozak, Sant P. Chawla, Steven Attia, Alfred Rademaker, Hui Zhang, Susan Abbinanti, Rasima Cehic, Varun Monga, Mohammed Milhem, Scott Okuno, Brian A. Van Tine
- Section of Medical Oncology
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences
- Neurofibromatosis (NF) Center
- Siteman Cancer Center
- DBBS - Molecular Cell Biology
- DBBS - Molecular Genetics and Genomics
- DBBS - Cancer Biology
Research output: Contribution to journal › Article › peer-review
8
Scopus
citations